ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
